Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Roger Douglas Weiss, M.D.

TitleProfessor of Psychiatry
InstitutionMcLean Hospital
DepartmentPsychiatry
AddressMclean Hospital
Psychiatry
115 Mill St
Belmont MA 02478
Phone617/855-2242
Fax617/855-2699

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Meade CS, Bevilacqua LA, Moore ED, Griffin ML, Gardin JG, Potter JS, Hatch-Maillette M, Weiss RD. Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence. Am J Addict. 2014 Jan; 23(1):27-33.
    View in: PubMed
  2. Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Degroot A, Edwards RR, Haddox JD, Jaffe JH, Jones CM, Kleber HD, Kopecky EA, Markman JD, Montoya ID, O'Brien C, Roland CL, Stanton M, Strain EC, Vorsanger G, Wasan AD, Weiss RD, Turk DC, Dworkin RH. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013 Nov; 154(11):2287-96.
    View in: PubMed
  3. Kiluk BD, Dreifuss JA, Weiss RD, Horigian VE, Carroll KM. Psychometric properties of a Spanish-language version of the Short Inventory of Problems. Psychol Addict Behav. 2013 Sep; 27(3):893-900.
    View in: PubMed
  4. Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ. Benzodiazepine use during buprenorphine treatment for opioid dependence: Clinical and safety outcomes. Drug Alcohol Depend. 2013 Oct 1; 132(3):580-6.
    View in: PubMed
  5. Hill KP, Toto LH, Lukas SE, Weiss RD, Trksak GH, Rodolico JM, Greenfield SF. Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study. Am J Addict. 2013 May; 22(3):233-8.
    View in: PubMed
  6. Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA, Weiss RD. Clinician beliefs and attitudes about buprenorphine/naloxone diversion. Am J Addict. 2013 Nov; 22(6):574-80.
    View in: PubMed
  7. Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, Woody GE, Weiss RD. Association of cannabis use with opioid outcomes among opioid-dependent youth. Drug Alcohol Depend. 2013 Sep 1; 132(1-2):342-5.
    View in: PubMed
  8. Levy B, Medina AM, Weiss RD. Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: A comparative longitudinal study. Compr Psychiatry. 2013 Aug; 54(6):618-26.
    View in: PubMed
  9. Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend. 2013 Jul 1; 131(1-2):112-8.
    View in: PubMed
  10. McHugh RK, Devito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013 Jul; 45(1):38-43.
    View in: PubMed
  11. Katz NP, Birnbaum H, Brennan MJ, Freedman JD, Gilmore GP, Jay D, Kenna GA, Madras BK, McElhaney L, Weiss RD, White AG. Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care. 2013; 19(4):295-302.
    View in: PubMed
  12. Weiss RD. Contingency management for patients with serious mental illness and stimulant dependence. Am J Psychiatry. 2013 Jan 1; 170(1):6-8.
    View in: PubMed
  13. McHugh RK, Kaufman JS, Frost KH, Fitzmaurice GM, Weiss RD. Positive affect and stress reactivity in alcohol-dependent outpatients. J Stud Alcohol Drugs. 2013 Jan; 74(1):152-7.
    View in: PubMed
  14. Devido JJ, Weiss RD. Treatment of the depressed alcoholic patient. Curr Psychiatry Rep. 2012 Dec; 14(6):610-8.
    View in: PubMed
  15. Farren CK, Hill KP, Weiss RD. Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep. 2012 Dec; 14(6):659-66.
    View in: PubMed
  16. Hill KP, Rice LS, Connery HS, Weiss RD. Diagnosing and treating opioid dependence. J Fam Pract. 2012 Oct; 61(10):588-97.
    View in: PubMed
  17. Keuroghlian AS, Barry AS, Weiss RD. Circadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work. Am J Addict. 2012 Nov; 21(6):576-7.
    View in: PubMed
  18. Turk DC, O'Connor AB, Dworkin RH, Chaudhry A, Katz NP, Adams EH, Brownstein JS, Comer SD, Dart R, Dasgupta N, Denisco RA, Klein M, Leiderman DB, Lubran R, Rappaport BA, Zacny JP, Ahdieh H, Burke LB, Cowan P, Jacobs P, Malamut R, Markman J, Michna E, Palmer P, Peirce-Sandner S, Potter JS, Raja SN, Rauschkolb C, Roland CL, Webster LR, Weiss RD, Wolf K. Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain. 2012 Oct; 153(10):1997-2008.
    View in: PubMed
  19. Kiluk BD, Dreifuss JA, Weiss RD, Morgenstern J, Carroll KM. The Short Inventory of Problems - Revised (SIP-R): Psychometric properties within a large, diverse sample of substance use disorder treatment seekers. Psychol Addict Behav. 2013 Mar; 27(1):307-14.
    View in: PubMed
  20. Levy B, Manove E, Weiss RD. Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episode. Ann Clin Psychiatry. 2012 May; 24(2):143-54.
    View in: PubMed
  21. Copersino ML, Schretlen DJ, Fitzmaurice GM, Lukas SE, Faberman J, Sokoloff J, Weiss RD. Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure. Am J Drug Alcohol Abuse. 2012 May; 38(3):246-50.
    View in: PubMed
  22. Wasan AD, Ross EL, Michna E, Chibnik L, Greenfield SF, Weiss RD, Jamison RN. Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial. J Pain. 2012 Feb; 13(2):146-54.
    View in: PubMed
  23. Putnins SI, Griffin ML, Fitzmaurice GM, Dodd DR, Weiss RD. Poor sleep at baseline predicts worse mood outcomes in patients with co-occurring bipolar disorder and substance dependence. J Clin Psychiatry. 2012 May; 73(5):703-8.
    View in: PubMed
  24. Kolodziej ME, Muchowski PM, Hamdi NR, Morrissette P, McGowan AJ, Weiss RD. Adaptation of the patient feedback survey at a community treatment setting. Am J Addict. 2012 Jan-Feb; 21(1):63-71.
    View in: PubMed
  25. Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011 Dec; 68(12):1238-46.
    View in: PubMed
  26. Meade CS, Fitzmaurice GM, Sanchez AK, Griffin ML, McDonald LJ, Weiss RD. The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis. AIDS Behav. 2011 Nov; 15(8):1829-33.
    View in: PubMed
  27. Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff B, Trivedi M, Weiss R, Potter J, Poole SA, Woody GE. Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am Acad Child Adolesc Psychiatry. 2011 Nov; 50(11):1120-8.
    View in: PubMed
  28. Ittiwut C, Yang BZ, Kranzler HR, Anton RF, Hirunsatit R, Weiss RD, Covault J, Farrer LA, Gelernter J. GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. Alcohol Clin Exp Res. 2012 Apr; 36(4):588-93.
    View in: PubMed
  29. Carroll KM, Ball SA, Jackson R, Martino S, Petry NM, Stitzer ML, Wells EA, Weiss RD. Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):275-82.
    View in: PubMed
  30. Potter JS, Donovan DM, Weiss RD, Gardin J, Lindblad R, Wakim P, Dodd D. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):400-7.
    View in: PubMed
  31. Teter CJ, Falone AE, Bakaian AM, Tu C, Ongür D, Weiss RD. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Res. 2011 Dec 30; 190(2-3):253-8.
    View in: PubMed
  32. Ittiwut R, Listman JB, Ittiwut C, Cubells JF, Weiss RD, Brady K, Oslin D, Farrer LA, Kranzler HR, Gelernter J. Association between polymorphisms in catechol-O-methyltransferase (COMT) and cocaine-induced paranoia in European-American and African-American populations. Am J Med Genet B Neuropsychiatr Genet. 2011 Sep; 156B(6):651-60.
    View in: PubMed
  33. Hamdi NR, Levy M, Jaffee WB, Chisholm SM, Weiss RD. Implementing an adapted version of the job seekers' workshop in a residential program for patients with substance use disorders. J Addict Med. 2011 Jun; 5(2):148-52.
    View in: PubMed
  34. Levy B, Medina AM, Manove E, Weiss RD. The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder. J Psychiatr Res. 2011 Aug; 45(8):1048-54.
    View in: PubMed
  35. McDonald LJ, Griffin ML, Kolodziej ME, Fitzmaurice GM, Weiss RD. The impact of drug use in social networks of patients with substance use and bipolar disorders. Am J Addict. 2011 Mar-Apr; 20(2):100-5.
    View in: PubMed
  36. Levy S, Knight JR, Moore T, Weinstein Z, Sherritt L, Weiss RD. Acceptability of drug testing in an outpatient substance abuse program for adolescents. J Adolesc Health. 2011 Mar; 48(3):229-33.
    View in: PubMed
  37. Zanarini MC, Frankenbur FR, Weingeroff JL, Reich DB, Fitzmaurice GM, Weiss RD. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction. 2011 Feb; 106(2):342-8.
    View in: PubMed
  38. Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE. HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):65-72.
    View in: PubMed
  39. Levy B, Medina AM, Hintz K, Weiss RD. Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder. Psychiatry Res. 2011 Feb 28; 185(3):353-7.
    View in: PubMed
  40. Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, Wallin D, Pendse G, McDonald L, Griffin M, Anderson J, Nutile L, Renshaw P, Weiss R, Becerra L, Borsook D. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain. 2010 Jul; 133(Pt 7):2098-114.
    View in: PubMed
  41. Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network. J Subst Abuse Treat. 2010 Jun; 38 Suppl 1:S80-6.
    View in: PubMed
  42. Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B. From research to the real world: buprenorphine in the decade of the Clinical Trials Network. J Subst Abuse Treat. 2010 Jun; 38 Suppl 1:S53-60.
    View in: PubMed
  43. Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010 Dec; 71(12):1680-8.
    View in: PubMed
  44. Liebschutz JM, Saitz R, Weiss RD, Averbuch T, Schwartz S, Meltzer EC, Claggett-Borne E, Cabral H, Samet JH. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain. 2010 Nov; 11(11):1047-55.
    View in: PubMed
  45. Weiss RD, Potter JS, Copersino ML, Prather K, Jacobs P, Provost S, Chim D, Selzer J, Ling W. Conducting clinical research with prescription opioid dependence: defining the population. Am J Addict. 2010 Mar-Apr; 19(2):141-6.
    View in: PubMed
  46. Panhuysen CI, Kranzler HR, Yu Y, Weiss RD, Brady K, Poling J, Farrer LA, Gelernter J. Confirmation and generalization of an alcohol-dependence locus on chromosome 10q. Neuropsychopharmacology. 2010 May; 35(6):1325-32.
    View in: PubMed
  47. Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology. Contemp Clin Trials. 2010 Mar; 31(2):189-99.
    View in: PubMed
  48. Potter JS, Prather K, Kropp F, Byrne M, Sullivan CR, Mohamedi N, Copersino ML, Weiss RD. A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemp Clin Trials. 2010 Mar; 31(2):185-8.
    View in: PubMed
  49. Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2010 Mar; 167(3):289-97.
    View in: PubMed
  50. Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug Alcohol Depend. 2010 Mar 1; 107(2-3):253-6.
    View in: PubMed
  51. Kalayasiri R, Gelernter J, Farrer L, Weiss R, Brady K, Gueorguieva R, Kranzler HR, Malison RT. Adolescent cannabis use increases risk for cocaine-induced paranoia. Drug Alcohol Depend. 2010 Mar 1; 107(2-3):196-201.
    View in: PubMed
  52. Levy B, Weiss RD. Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance. J Clin Psychiatry. 2010 Feb; 71(2):201-6.
    View in: PubMed
  53. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K, Weiss RD, Farrer L, Gelernter J. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry. 2009 Nov; 66(11):1201-9.
    View in: PubMed
  54. Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol. 2009 Oct; 17(5):337-44.
    View in: PubMed
  55. Douglas KR, Chan G, Gelernter J, Arias AJ, Anton RF, Weiss RD, Brady K, Poling J, Farrer L, Kranzler HR. Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addict Behav. 2010 Jan; 35(1):7-13.
    View in: PubMed
  56. Niciu MJ, Chan G, Gelernter J, Arias AJ, Douglas K, Weiss R, Anton RF, Farrer L, Cubells JF, Kranzler HR. Subtypes of major depression in substance dependence. Addiction. 2009 Oct; 104(10):1700-9.
    View in: PubMed
  57. Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS, Gallop RJ, Fitzmaurice GM. A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend. 2009 Oct 1; 104(3):212-9.
    View in: PubMed
  58. Meade CS, Lukas SE, McDonald LJ, Fitzmaurice GM, Eldridge JA, Merrill N, Weiss RD. A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification. J Subst Abuse Treat. 2010 Jan; 38(1):12-21.
    View in: PubMed
  59. Meade CS, McDonald LJ, Weiss RD. HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users. Am J Addict. 2009 Jul-Aug; 18(4):289-93.
    View in: PubMed
  60. Wu LT, Ringwalt CL, Weiss RD, Blazer DG. Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use. Drug Alcohol Depend. 2009 Sep 1; 104(1-2):156-66.
    View in: PubMed
  61. Hughes JR, Weiss RD. Are differences in guidelines for the treatment of nicotine dependence and non-nicotine dependence justified? Addiction. 2009 Dec; 104(12):1951-7.
    View in: PubMed
  62. Meade CS, McDonald LJ, Graff FS, Fitzmaurice GM, Griffin ML, Weiss RD. A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. Bipolar Disord. 2009 Jun; 11(4):425-33.
    View in: PubMed
  63. McGovern MP, Lambert-Harris C, Acquilano S, Xie H, Alterman AI, Weiss RD. A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders. Addict Behav. 2009 Oct; 34(10):892-7.
    View in: PubMed
  64. Griffin ML, Kolodziej ME, Weiss RD. Measuring principal substance of abuse in comorbid patients for clinical research. Addict Behav. 2009 Oct; 34(10):826-9.
    View in: PubMed
  65. Wasan AD, Butler SF, Budman SH, Fernandez K, Weiss RD, Greenfield SF, Jamison RN. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain. 2009 Mar-Apr; 25(3):193-8.
    View in: PubMed
  66. Farrer LA, Kranzler HR, Yu Y, Weiss RD, Brady KT, Anton R, Cubells JF, Gelernter J. Association of variants in MANEA with cocaine-related behaviors. Arch Gen Psychiatry. 2009 Mar; 66(3):267-74.
    View in: PubMed
  67. Zhang H, Kranzler HR, Weiss RD, Luo X, Brady KT, Anton RF, Farrer LA, Gelernter J. Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry. 2009 Jul 15; 66(2):128-36.
    View in: PubMed
  68. Levy B, Weiss RD. Cognitive functioning in bipolar and co-occurring substance use disorders: a missing piece of the puzzle. Harv Rev Psychiatry. 2009; 17(3):226-30.
    View in: PubMed
  69. Jaffee WB, Bailey GL, Lohman M, Riggs P, McDonald L, Weiss RD. Methods of recruiting adolescents with psychiatric and substance use disorders for a clinical trial. Am J Drug Alcohol Abuse. 2009; 35(5):381-4.
    View in: PubMed
  70. Jaffee WB, Griffin ML, Gallop R, Meade CS, Graff F, Bender RE, Weiss RD. Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. J Clin Psychiatry. 2009 Feb; 70(2):171-6.
    View in: PubMed
  71. Zuo L, Kranzler HR, Luo X, Yang BZ, Weiss R, Brady K, Poling J, Farrer L, Gelernter J. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Neuropsychopharmacology. 2009 May; 34(6):1504-13.
    View in: PubMed
  72. Levy B, Stephansky MR, Dobie KC, Monzani BA, Medina AM, Weiss RD. The duration of inpatient admission predicts cognitive functioning at discharge in patients with bipolar disorder. Compr Psychiatry. 2009 Jul-Aug; 50(4):322-6.
    View in: PubMed
  73. Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study. J Stud Alcohol Drugs. 2008 Nov; 69(6):878-84.
    View in: PubMed
  74. Gelernter J, Kranzler HR, Panhuysen C, Weiss RD, Brady K, Poling J, Farrer L. Dense genomewide linkage scan for alcohol dependence in African Americans: significant linkage on chromosome 10. Biol Psychiatry. 2009 Jan 15; 65(2):111-5.
    View in: PubMed
  75. Bieber CM, Fernandez K, Borsook D, Brennan MJ, Butler SF, Jamison RN, Osgood E, Sharpe-Potter J, Thomson HN, Weiss RD, Katz NP. Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Exp Clin Psychopharmacol. 2008 Oct; 16(5):429-34.
    View in: PubMed
  76. Ford JD, Gelernter J, DeVoe JS, Zhang W, Weiss RD, Brady K, Farrer L, Kranzler HR. Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. Drug Alcohol Depend. 2009 Jan 1; 99(1-3):193-203.
    View in: PubMed
  77. Ernst DB, Pettinati HM, Weiss RD, Donovan DM, Longabaugh R. An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care. Ann Fam Med. 2008 Sep-Oct; 6(5):435-40.
    View in: PubMed
  78. Levy B, Monzani BA, Stephansky MR, Weiss RD. Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. Psychiatry Res. 2008 Oct 30; 161(1):28-35.
    View in: PubMed
  79. Zweben A, Pettinati HM, Weiss RD, Youngblood M, Cox CE, Mattson ME, Gorroochurn P, Ciraulo D. Relationship between medication adherence and treatment outcomes: the COMBINE study. Alcohol Clin Exp Res. 2008 Sep; 32(9):1661-9.
    View in: PubMed
  80. Paul D, Sullivan MA, Weiss RD. Response: providing relief, avoiding euphoria. Addict Sci Clin Pract. 2008 Jun; 4(2):26-7.
    View in: PubMed
  81. Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, Kranzler HR. Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 2008 Sep; 33(9):1199-207.
    View in: PubMed
  82. Worley M, Gallop R, Gibbons MB, Ring-Kurtz S, Present J, Weiss RD, Crits-Christoph P. Additional treatment services in a cocaine treatment study: level of services obtained and impact on outcome. Am J Addict. 2008 May-Jun; 17(3):209-17.
    View in: PubMed
  83. Yu Y, Kranzler HR, Panhuysen C, Weiss RD, Poling J, Farrer LA, Gelernter J. Substance dependence low-density whole genome association study in two distinct American populations. Hum Genet. 2008 Jun; 123(5):495-506.
    View in: PubMed
  84. Schatzberg AF, Weiss RD, Brady KT, Culpepper L. Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction. CNS Spectr. 2008 Apr; 13(4 Suppl 6):3.
    View in: PubMed
  85. Weiss RD. Identifying and diagnosing co-occurring disorders. CNS Spectr. 2008 Apr; 13(4 Suppl 6):4-6.
    View in: PubMed
  86. Potter JS, Prather K, Weiss RD. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict. 2008 Mar-Apr; 17(2):121-5.
    View in: PubMed
  87. Jaffee WB, Trucco E, Teter C, Levy S, Weiss RD. Focus on alcohol & drug abuse: ensuring validity in urine drug testing. Psychiatr Serv. 2008 Feb; 59(2):140-2.
    View in: PubMed
  88. Potter JS, Shiffman SJ, Weiss RD. Chronic pain severity in opioid-dependent patients. Am J Drug Alcohol Abuse. 2008; 34(1):101-7.
    View in: PubMed
  89. Graff FS, Griffin ML, Weiss RD. Predictors of dropout from group therapy among patients with bipolar and substance use disorders. Drug Alcohol Depend. 2008 Apr 1; 94(1-3):272-5.
    View in: PubMed
  90. Bender RE, Griffin ML, Gallop RJ, Weiss RD. Assessing negative consequences in patients with substance use and bipolar disorders: psychometric properties of the short inventory of problems (SIP). Am J Addict. 2007 Nov-Dec; 16(6):503-9.
    View in: PubMed
  91. Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, Grudzinskas C, Jasinski D, Lande SD, Passik SD, Schnoll SH, Sellers E, Travers D, Weiss R. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain. 2007 Oct; 23(8):648-60.
    View in: PubMed
  92. Meade CS, Graff FS, Griffin ML, Weiss RD. HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse. Drug Alcohol Depend. 2008 Jan 1; 92(1-3):296-300.
    View in: PubMed
  93. Pomykacz B, Mao M, Weiss RD, Teter CJ. A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder. Harv Rev Psychiatry. 2007 Sep-Oct; 15(5):259-63.
    View in: PubMed
  94. Manwani SG, Szilagyi KA, Zablotsky B, Hennen J, Griffin ML, Weiss RD. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry. 2007 Aug; 68(8):1172-6.
    View in: PubMed
  95. Kolodziej ME, Griffin ML, Bender R, Weiss RD. Assessment of depressive symptom severity among patients with co-occurring bipolar disorder and substance dependence. J Affect Disord. 2008 Feb; 106(1-2):83-9.
    View in: PubMed
  96. Kranzler HR, Wilcox M, Weiss RD, Brady K, Hesselbrock V, Rounsaville B, Farrer L, Gelernter J. The validity of cocaine dependence subtypes. Addict Behav. 2008 Jan; 33(1):41-53.
    View in: PubMed
  97. Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnovitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007 Apr; 164(4 Suppl):5-123.
    View in: PubMed
  98. Jaffee WB, Trucco E, Levy S, Weiss RD. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat. 2007 Jul; 33(1):33-42.
    View in: PubMed
  99. Shields AL, Howell RT, Potter JS, Weiss RD. The Michigan Alcoholism Screening Test and its shortened form: a meta-analytic inquiry into score reliability. Subst Use Misuse. 2007; 42(11):1783-800.
    View in: PubMed
  100. Weiss RD, Griffin ML, Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, Doreau HR, Hennen JA. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry. 2007 Jan; 164(1):100-7.
    View in: PubMed
  101. Ostacher MJ, Nierenberg AA, Perlis RH, Eidelman P, Borrelli DJ, Tran TB, Marzilli Ericson G, Weiss RD, Sachs GS. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry. 2006 Dec; 67(12):1907-11.
    View in: PubMed
  102. Weiss RD, Kueppenbender KD. Combining psychosocial treatment with pharmacotherapy for alcohol dependence. J Clin Psychopharmacol. 2006 Dec; 26 Suppl 1:S37-42.
    View in: PubMed
  103. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet. 2006 Dec 15; 15(24):3498-507.
    View in: PubMed
  104. Gelernter J, Panhuysen C, Weiss R, Brady K, Poling J, Krauthammer M, Farrer L, Kranzler HR. Genomewide linkage scan for nicotine dependence: identification of a chromosome 5 risk locus. Biol Psychiatry. 2007 Jan 1; 61(1):119-26.
    View in: PubMed
  105. Najavits LM, Gallop RJ, Weiss RD. Seeking safety therapy for adolescent girls with PTSD and substance use disorder: a randomized controlled trial. J Behav Health Serv Res. 2006 Oct; 33(4):453-63.
    View in: PubMed
  106. Harned MS, Najavits LM, Weiss RD. Self-harm and suicidal behavior in women with comorbid PTSD and substance dependence. Am J Addict. 2006 Sep-Oct; 15(5):392-5.
    View in: PubMed
  107. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry. 2006 Aug; 163(8 Suppl):5-82.
    View in: PubMed
  108. Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5.
    View in: PubMed
  109. Yu Y, Panhuysen C, Kranzler HR, Hesselbrock V, Rounsaville B, Weiss R, Brady K, Farrer LA, Gelernter J. Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans. Hum Mol Genet. 2006 Jul 15; 15(14):2192-9.
    View in: PubMed
  110. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006 May 3; 295(17):2003-17.
    View in: PubMed
  111. Gelernter J, Panhuysen C, Wilcox M, Hesselbrock V, Rounsaville B, Poling J, Weiss R, Sonne S, Zhao H, Farrer L, Kranzler HR. Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet. 2006 May; 78(5):759-69.
    View in: PubMed
  112. Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, Miklowitz DJ, Coon KA, Ostacher MJ, Neel JL, Thase ME, Sachs GS, Weiss RD. Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. Am J Addict. 2006 Mar-Apr; 15(2):138-43.
    View in: PubMed
  113. Miller WR, Baca C, Compton WM, Ernst D, Manuel JK, Pringle B, Schermer CR, Weiss RD, Willenbring ML, Zweben A. Addressing substance abuse in health care settings. Alcohol Clin Exp Res. 2006 Feb; 30(2):292-302.
    View in: PubMed
  114. Kalayasiri R, Kranzler HR, Weiss R, Brady K, Gueorguieva R, Panhuysen C, Yang BZ, Farrer L, Gelernter J, Malison RT. Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs. Drug Alcohol Depend. 2006 Sep 1; 84(1):77-84.
    View in: PubMed
  115. Najavits LM, Schmitz M, Gotthardt S, Weiss RD. Seeking Safety plus Exposure Therapy: an outcome study on dual diagnosis men. J Psychoactive Drugs. 2005 Dec; 37(4):425-35.
    View in: PubMed
  116. Kolodziej ME, Griffin ML, Najavits LM, Otto MW, Greenfield SF, Weiss RD. Anxiety disorders among patients with co-occurring bipolar and substance use disorders. Drug Alcohol Depend. 2005 Nov 1; 80(2):251-7.
    View in: PubMed
  117. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract. 2005 Sep; 11(5):315-39.
    View in: PubMed
  118. Gelernter J, Panhuysen C, Weiss R, Brady K, Hesselbrock V, Rounsaville B, Poling J, Wilcox M, Farrer L, Kranzler HR. Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am J Med Genet B Neuropsychiatr Genet. 2005 Jul 5; 136B(1):45-52.
    View in: PubMed
  119. Weiss RD, Locastro JS, Swift R, Zweben A, Miller WR, Longabaugh R, Hosking JD. Use of a "psychotherapy with no pills" treatment condition as part of a combined pharmacotherapy-psychotherapy research study of alcohol dependence. J Stud Alcohol Suppl. 2005 Jul; (15):43-9; discussion 33.
    View in: PubMed
  120. Pettinati HM, Weiss RD, Dundon W, Miller WR, Donovan D, Ernst DB, Rounsaville BJ. A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J Stud Alcohol Suppl. 2005 Jul; (15):170-8; discussion 168-9.
    View in: PubMed
  121. Greenfield SF, Sugarman DE, Nargiso J, Weiss RD. Readability of patient handout materials in a nationwide sample of alcohol and drug abuse treatment programs. Am J Addict. 2005 Jul-Sep; 14(4):339-45.
    View in: PubMed
  122. Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
    View in: PubMed
  123. Weiss RD, Griffin ML, Gallop RJ, Najavits LM, Frank A, Crits-Christoph P, Thase ME, Blaine J, Gastfriend DR, Daley D, Luborsky L. The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients. Drug Alcohol Depend. 2005 Feb 14; 77(2):177-84.
    View in: PubMed
  124. Weiss RD. Treating patients with bipolar disorder and substance dependence: lessons learned. J Subst Abuse Treat. 2004 Dec; 27(4):307-12.
    View in: PubMed
  125. Potter JS, Hennessy G, Borrow JA, Greenfield SF, Weiss RD. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend. 2004 Nov 11; 76(2):213-5.
    View in: PubMed
  126. Weiss RD. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction. 2004 Nov; 99(11):1382-92.
    View in: PubMed
  127. Weiss RD, Jaffee WB, de Menil VP, Cogley CB. Group therapy for substance use disorders: what do we know? Harv Rev Psychiatry. 2004 Nov-Dec; 12(6):339-50.
    View in: PubMed
  128. Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
    View in: PubMed
  129. Najavits LM, Sonn J, Walsh M, Weiss RD. Domestic violence in women with PTSD and substance abuse. Addict Behav. 2004 Jun; 29(4):707-15.
    View in: PubMed
  130. Najavits LM, Sullivan TP, Schmitz M, Weiss RD, Lee CS. Treatment utilization by women with PTSD and substance dependence. Am J Addict. 2004 May-Jun; 13(3):215-24.
    View in: PubMed
  131. Weiss RD, Kolodziej M, Griffin ML, Najavits LM, Jacobson LM, Greenfield SF. Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence. J Affect Disord. 2004 Apr; 79(1-3):279-83.
    View in: PubMed
  132. Humphreys K, Wing S, McCarty D, Chappel J, Gallant L, Haberle B, Horvath AT, Kaskutas LA, Kirk T, Kivlahan D, Laudet A, McCrady BS, McLellan AT, Morgenstern J, Townsend M, Weiss R. Self-help organizations for alcohol and drug problems: toward evidence-based practice and policy. J Subst Abuse Treat. 2004 Apr; 26(3):151-8; discussion 159-65.
    View in: PubMed
  133. Hennessy GO, De Menil V, Weiss RD. Psychosocial treatments for cocaine dependence. Curr Psychiatry Rep. 2003 Oct; 5(5):362-4.
    View in: PubMed
  134. Crits-Christoph P, Gibbons MB, Barber JP, Gallop R, Beck AT, Mercer D, Tu X, Thase ME, Weiss RD, Frank A. Mediators of outcome of psychosocial treatments for cocaine dependence. J Consult Clin Psychol. 2003 Oct; 71(5):918-25.
    View in: PubMed
  135. Dickey B, Normand SL, Drake R, Weiss RD, Azeni H, Hanson A. Limiting inpatient substance use treatment: what are the consequences? Med Care Res Rev. 2003 Sep; 60(3):332-46.
    View in: PubMed
  136. Greenfield SF, Sugarman DE, Muenz LR, Patterson MD, He DY, Weiss RD. The relationship between educational attainment and relapse among alcohol-dependent men and women: a prospective study. Alcohol Clin Exp Res. 2003 Aug; 27(8):1278-85.
    View in: PubMed
  137. Weiss RD, Griffin ML, Mazurick C, Berkman B, Gastfriend DR, Frank A, Barber JP, Blaine J, Salloum I, Moras K. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry. 2003 Jul; 160(7):1320-5.
    View in: PubMed
  138. Kanayama G, Cohane GH, Weiss RD, Pope HG. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry. 2003 Feb; 64(2):156-60.
    View in: PubMed
  139. Greenfield SF, Hennessy G, Sugarman DE, Weiss RD. What general psychiatrists ask addiction psychiatrists: a review of 381 substance abuse consultations in a psychiatric hospital. Am J Addict. 2003 Jan-Feb; 12(1):18-28.
    View in: PubMed
  140. Greenfield SF, Kolodziej ME, Sugarman DE, Muenz LR, Vagge LM, He DY, Weiss RD. History of abuse and drinking outcomes following inpatient alcohol treatment: a prospective study. Drug Alcohol Depend. 2002 Aug 1; 67(3):227-34.
    View in: PubMed
  141. Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv. 2002 Jul; 53(7):861-7.
    View in: PubMed
  142. O'Leary G, Borrow J, Weiss RD. Opioid antagonists in the treatment of alcohol dependence. Curr Psychiatry Rep. 2001 Dec; 3(6):484-8.
    View in: PubMed
  143. O'Leary G, Nargiso J, Weiss RD. 3,4-methylenedioxymethamphetamine (MDMA): a review. Curr Psychiatry Rep. 2001 Dec; 3(6):477-83.
    View in: PubMed
  144. Crits-Christoph P, Siqueland L, McCalmont E, Weiss RD, Gastfriend DR, Frank A, Moras K, Barber JP, Blaine J, Thase ME. Impact of psychosocial treatments on associated problems of cocaine-dependent patients. J Consult Clin Psychol. 2001 Oct; 69(5):825-30.
    View in: PubMed
  145. Barber JP, Luborsky L, Gallop R, Crits-Christoph P, Frank A, Weiss RD, Thase ME, Connolly MB, Gladis M, Foltz C, Siqueland L. Therapeutic alliance as a predictor of outcome and retention in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. J Consult Clin Psychol. 2001 Feb; 69(1):119-24.
    View in: PubMed
  146. O'Leary G, Weiss RD. Pharmacotherapies for cocaine dependence. Curr Psychiatry Rep. 2000 Dec; 2(6):508-13.
    View in: PubMed
  147. Weiss RD, Griffin ML, Gallop R, Luborsky L, Siqueland L, Frank A, Onken LS, Daley DC, Gastfriend DR. Predictors of self-help group attendance in cocaine dependent patients. J Stud Alcohol. 2000 Sep; 61(5):714-9.
    View in: PubMed
  148. Weiss RD, Griffin ML, Gallop R, Onken LS, Gastfriend DR, Daley D, Crits-Christoph P, Bishop S, Barber JP. Self-help group attendance and participation among cocaine dependent patients. Drug Alcohol Depend. 2000 Aug 1; 60(2):169-77.
    View in: PubMed
  149. Weiss RD, Greenfield SF, Griffin ML, Najavits LM, Fucito LM. The use of collateral reports for patients with bipolar and substance use disorders. Am J Drug Alcohol Abuse. 2000 Aug; 26(3):369-78.
    View in: PubMed
  150. Weiss RD, Griffin ML, Greenfield SF, Najavits LM, Wyner D, Soto JA, Hennen JA. Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. J Clin Psychiatry. 2000 May; 61(5):361-7.
    View in: PubMed
  151. Dickey B, Azeni H, Weiss R, Sederer L. Schizophrenia, substance use disorders and medical co-morbidity. J Ment Health Policy Econ. 2000 Mar 1; 3(1):27-33.
    View in: PubMed
  152. Greenfield SF, Hufford MR, Vagge LM, Muenz LR, Costello ME, Weiss RD. The relationship of self-efficacy expectancies to relapse among alcohol dependent men and women: a prospective study. J Stud Alcohol. 2000 Mar; 61(2):345-51.
    View in: PubMed
  153. Weiss RD, Kolodziej ME, Najavits LM, Greenfield SF, Fucito LM. Utilization of psychosocial treatments by patients diagnosed with bipolar disorder and substance dependence. Am J Addict. 2000; 9(4):314-20.
    View in: PubMed
  154. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz LR, Thase ME, Weiss RD, Gastfriend DR, Woody GE, Barber JP, Butler SF, Daley D, Salloum I, Bishop S, Najavits LM, Lis J, Mercer D, Griffin ML, Moras K, Beck AT. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry. 1999 Jun; 56(6):493-502.
    View in: PubMed
  155. Wines JD, Weiss RD. Opioid withdrawal during risperidone treatment. J Clin Psychopharmacol. 1999 Jun; 19(3):265-7.
    View in: PubMed
  156. Weiss RD, Najavits LM, Greenfield SF. A relapse prevention group for patients with bipolar and substance use disorders. J Subst Abuse Treat. 1999 Jan; 16(1):47-54.
    View in: PubMed
  157. Tohen M, Greenfield SF, Weiss RD, Zarate CA, Vagge LM. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv Rev Psychiatry. 1998 Sep-Oct; 6(3):133-41.
    View in: PubMed
  158. Najavits LM, Weiss RD, Shaw SR, Muenz LR. "Seeking safety": outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence. J Trauma Stress. 1998 Jul; 11(3):437-56.
    View in: PubMed
  159. Weiss RD, Greenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, Griffin ML. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry. 1998 Apr; 59(4):172-4.
    View in: PubMed
  160. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, Michael J. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry. 1998 Mar; 55(3):259-65.
    View in: PubMed
  161. Najavits LM, Gastfriend DR, Barber JP, Reif S, Muenz LR, Blaine J, Frank A, Crits-Christoph P, Thase M, Weiss RD. Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Am J Psychiatry. 1998 Feb; 155(2):214-9.
    View in: PubMed
  162. Weiss RD, Najavits LM, Greenfield SF, Soto JA, Shaw SR, Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. Am J Psychiatry. 1998 Jan; 155(1):127-8.
    View in: PubMed
  163. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, Kukes TJ, Renshaw PF. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry. 1998 Jan; 155(1):124-6.
    View in: PubMed
  164. Najavits LM, Weiss RD, Reif S, Gastfriend DR, Siqueland L, Barber JP, Butler SF, Thase M, Blaine J. The Addiction Severity Index as a screen for trauma and posttraumatic stress disorder. J Stud Alcohol. 1998 Jan; 59(1):56-62.
    View in: PubMed
  165. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz L, Thase ME, Weiss RD, Gastfriend DR, Woody G, Barber JP, Butler SF, Daley D, Bishop S, Najavits LM, Lis J, Mercer D, Griffin ML, Moras K, Beck AT. The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods. Arch Gen Psychiatry. 1997 Aug; 54(8):721-6.
    View in: PubMed
  166. Weiss RD, Martinez-Raga J, Griffin ML, Greenfield SF, Hufford C. Gender differences in cocaine dependent patients: a 6 month follow-up study. Drug Alcohol Depend. 1997 Jan 10; 44(1):35-40.
    View in: PubMed
  167. Najavits LM, Weiss RD, Shaw SR. The link between substance abuse and posttraumatic stress disorder in women. A research review. Am J Addict. 1997; 6(4):273-83.
    View in: PubMed
  168. Weiss RD, Griffin ML, Hufford C, Muenz LR, Najavits LM, Jansson SB, Kogan J, Thompson HJ. Early prediction of initiation of abstinence from cocaine. Use of a craving questionnaire. Am J Addict. 1997; 6(3):224-31.
    View in: PubMed
  169. Weiss RD, Griffin ML, Najavits LM, Hufford C, Kogan J, Thompson HJ, Albeck JH, Bishop S, Daley DC, Mercer D, Siqueland L. Self-help activities in cocaine dependent patients entering treatment: results from NIDA collaborative cocaine treatment study. Drug Alcohol Depend. 1996 Dec 2; 43(1-2):79-86.
    View in: PubMed
  170. Weiss RD, Martínez-Raga J, Hufford C. The significance of a coexisting opioid use disorder in cocaine dependence: an empirical study. Am J Drug Alcohol Abuse. 1996 May; 22(2):173-84.
    View in: PubMed
  171. Gorski NP, Nouraldin H, Dube DM, Preffer FI, Dombkowski DM, Villa EM, Lewandrowski KB, Weiss RD, Hufford C, Laposata M. Reduced fatty acid ethyl ester synthase activity in the white blood cells of alcoholics. Alcohol Clin Exp Res. 1996 Apr; 20(2):268-74.
    View in: PubMed
  172. Najavits LM, Weiss RD, Liese BS. Group cognitive-behavioral therapy for women with PTSD and substance use disorder. J Subst Abuse Treat. 1996 Jan-Feb; 13(1):13-22.
    View in: PubMed
  173. Weiss RD. Nicotine toxicity misdiagnosed as lithium toxicity. Am J Psychiatry. 1996 Jan; 153(1):132.
    View in: PubMed
  174. Weiss RD, Najavits LM, Muenz LR, Hufford C. Twelve-month test-retest reliability of the structured clinical interview for DSM-III-R personality disorders in cocaine-dependent patients. Compr Psychiatry. 1995 Sep-Oct; 36(5):384-9.
    View in: PubMed
  175. Weiss RD, Griffin ML, Hufford C. Craving in hospitalized cocaine abusers as a predictor of outcome. Am J Drug Alcohol Abuse. 1995 Aug; 21(3):289-301.
    View in: PubMed
  176. Greenfield SF, Weiss RD, Tohen M. Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital. Community Ment Health J. 1995 Jun; 31(3):265-77.
    View in: PubMed
  177. Weiss RD, Greenfield SF, Najavits LM. Integrating psychological and pharmacological treatment of dually diagnosed patients. NIDA Res Monogr. 1995; 150:110-28.
    View in: PubMed
  178. Najavits LM, Weiss RD. The role of psychotherapy in the treatment of substance-use disorders. Harv Rev Psychiatry. 1994 Jul-Aug; 2(2):84-96.
    View in: PubMed
  179. Najavits LM, Weiss RD. Variations in therapist effectiveness in the treatment of patients with substance use disorders: an empirical review. Addiction. 1994 Jun; 89(6):679-88.
    View in: PubMed
  180. Weiss RD, Hufford C, Mendelson JH. Serum prolactin levels and treatment outcome in cocaine dependence. Biol Psychiatry. 1994 Apr 15; 35(8):573-4.
    View in: PubMed
  181. Weiss RD, Mirin SM, Griffin ML, Gunderson JG, Hufford C. Personality disorders in cocaine dependence. Compr Psychiatry. 1993 May-Jun; 34(3):145-9.
    View in: PubMed
  182. Weiss RD, Griffin ML, Hufford C. Severity of cocaine dependence as a predictor of relapse to cocaine use. Am J Psychiatry. 1992 Nov; 149(11):1595-6.
    View in: PubMed
  183. Weiss RD, Mirin SM, Griffin ML. Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers. Br J Addict. 1992 Feb; 87(2):179-87.
    View in: PubMed
  184. Weiss RD, Mirin SM, Frances RJ. Alcohol & drug abuse. The myth of the typical dual diagnosis patient. Hosp Community Psychiatry. 1992 Feb; 43(2):107-8.
    View in: PubMed
  185. Greenfield SF, Weiss RD, Griffin ML. Patients who use drugs during inpatient substance abuse treatment. Am J Psychiatry. 1992 Feb; 149(2):235-9.
    View in: PubMed
  186. Weiss RD, Griffin ML, Mirin SM. Drug abuse as self-medication for depression: an empirical study. Am J Drug Alcohol Abuse. 1992; 18(2):121-9.
    View in: PubMed
  187. Hudson JI, Weiss RD, Pope HG, McElroy SK, Mirin SM. Eating disorders in hospitalized substance abusers. Am J Drug Alcohol Abuse. 1992; 18(1):75-85.
    View in: PubMed
  188. Mirin SM, Weiss RD, Griffin ML, Michael JL. Psychopathology in drug abusers and their families. Compr Psychiatry. 1991 Jan-Feb; 32(1):36-51.
    View in: PubMed
  189. Kroft CL, Gescuk B, Woods BT, Mello NK, Weiss RD, Mendelson JH. Brain ventricular size in female alcoholics: an MRI study. Alcohol. 1991 Jan-Feb; 8(1):31-4.
    View in: PubMed
  190. Weiss RD, Mirin SM. Tricyclic antidepressants in the treatment of alcoholism and drug abuse. J Clin Psychiatry. 1989 Jul; 50 Suppl:4-9; discussion 9-11.
    View in: PubMed
  191. Weiss RD, Griffin ML, Mirin SM. Diagnosing major depression in cocaine abusers: the use of depression rating scales. Psychiatry Res. 1989 Jun; 28(3):335-43.
    View in: PubMed
  192. Adelman SA, Weiss RD. What is therapeutic about inpatient alcoholism treatment? Hosp Community Psychiatry. 1989 May; 40(5):515-9.
    View in: PubMed
  193. Griffin ML, Weiss RD, Mirin SM, Lange U. A comparison of male and female cocaine abusers. Arch Gen Psychiatry. 1989 Feb; 46(2):122-6.
    View in: PubMed
  194. Amass L, Lukas SE, Weiss RD, Mendelson J. Evaluation of cognitive skills in ethanol- and cocaine- dependent patients during detoxification using P300 evoked response potentials (ERPs). NIDA Res Monogr. 1989; 95:353-4.
    View in: PubMed
  195. McElroy SL, Weiss RD, Mendelson JH, Teoh SK, McAfee B, Mello NK. Desipramine treatment for relapse prevention in cocaine dependence. NIDA Res Monogr. 1989; 95:57-63.
    View in: PubMed
  196. Weiss RD, Mirin SM, Griffin ML, Michael JL. Psychopathology in cocaine abusers. Changing trends. J Nerv Ment Dis. 1988 Dec; 176(12):719-25.
    View in: PubMed
  197. Weiss RD, Gawin FH. Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers. Am J Med. 1988 Dec; 85(6):879-80.
    View in: PubMed
  198. Weiss RD. Relapse to cocaine abuse after initiating desipramine treatment. JAMA. 1988 Nov 4; 260(17):2545-6.
    View in: PubMed
  199. Weiss RD, Mirin SM, Griffin ML, Michael JL. A comparison of alcoholic and nonalcoholic drug abusers. J Stud Alcohol. 1988 Nov; 49(6):510-5.
    View in: PubMed
  200. Mirin SM, Weiss RD, Michael J, Griffin ML. Psychopathology in substance abusers: diagnosis and treatment. Am J Drug Alcohol Abuse. 1988; 14(2):139-57.
    View in: PubMed
  201. Weiss RD, Tilles DS, Goldenheim PD, Mirin SM. Decreased single breath carbon monoxide diffusing capacity in cocaine freebase smokers. Drug Alcohol Depend. 1987 May; 19(3):271-6.
    View in: PubMed
  202. Griffin ML, Weiss RD, Mirin SM, Wilson H, Bouchard-Voelk B. The use of the Diagnostic Interview Schedule in drug-dependent patients. Am J Drug Alcohol Abuse. 1987; 13(3):281-91.
    View in: PubMed
  203. Weiss RD, Mirin SM. Subtypes of cocaine abusers. Psychiatr Clin North Am. 1986 Sep; 9(3):491-501.
    View in: PubMed
  204. Weiss RD, Mirin SM, Michael JL, Sollogub AC. Psychopathology in chronic cocaine abusers. Am J Drug Alcohol Abuse. 1986; 12(1-2):17-29.
    View in: PubMed
  205. Weiss RD, Pope HG, Mirin SM. Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline. Drug Alcohol Depend. 1985 May; 15(1-2):69-72.
    View in: PubMed
  206. Weiss RD, Mirin SM. Substance abuse as an attempt at self-medication. Psychiatr Med. 1985; 3(4):357-67.
    View in: PubMed
  207. Weiss RD, Goldenheim PD, Mirin SM, Hales CA, Mendelson JH. Pulmonary dysfunction in cocaine smokers. Am J Psychiatry. 1981 Aug; 138(8):1110-2.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Weiss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_